MACROGENICS INC Business Operations Contracts & Agreements
11 Contracts & Agreements
- Collaboration Agreements (5 contracts)
- Indemnification Agreements (1)
- Sales Agreements (2)
- Services Agreements (1)
- Supply Agreements (2)
- Fourth Amendment to the Collaboration and License Agreement by and between the Company and Incyte Corporation, Inc., dated July 24, 2024 (Filed With SEC on November 5, 2024)
- First Amendment to the Collaboration and License Agreement by and between the Company and Gilead Sciences, Inc., dated (Filed With SEC on May 9, 2024)
- Amendment No. 2 to the Global Collaboration and License Agreement by and between the Company and Incyte Corporation, dated April 7, 2022 (Filed With SEC on August 8, 2022)
- Collaboration and License Agreement by and between the Company and Zai Lab US LLC, dated June 15, 2021 (Filed With SEC on July 29, 2021)
- Amendment No. 1 to Sales Agreement, dated April 29, 2021, between MacroGenics, Inc. and Cowen and Company, LLC (Filed With SEC on April 29, 2021)
- Product Commercialization Agreement by and between the Company and Eversana Life Science Service (Filed With SEC on February 25, 2021)
- Commercial Supply Agreement by and between Incyte Corporation and the Company, dated (Filed With SEC on February 25, 2021)
- Commercial Supply Agreement by and between (Filed With SEC on February 25, 2021)
- Amendment No. 1 to Sales Agreement, dated June 19, 2020, between MacroGenics, Inc. and Cowen and Company, LLC (Filed With SEC on June 19, 2020)
- Amendment No, 1 to the Global Collaboration and License Agreement by and between the Company and Incyte Corporation, dated March 15, 2018 (Filed With SEC on May 7, 2018)
- INDEMNIFICATION AGREEMENT (Filed With SEC on October 1, 2013)
